Vopratelimab (Mouse IgG2a)
Vopratelimab (Mouse IgG2a) is a monoclonal antibody that selectively targets Inducible CO-Stimulator of T cells (ICOS). The variable region of Vopratelimab (Mouse IgG2a) is consistent with that of Vopratelimab , while the constant region is of Mouse IgG2a sequence. Vopratelimab (Mouse IgG2a) has antitumor immune response and enhances combinatorial efficacy with anti-PD-1 (HY-P9902A) therapy[1].
Product Specifications
UNSPSC
12352203
Target
Others
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
97.00
Smiles
[Vopratelimab(MouseIgG2a)]
Molecular Weight
(146.67 kDa)
References & Citations
[1]Hanson A, et al. ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models. PLoS One. 2020 Sep 24;15 (9) :e0239595.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
15964061 1.0 µg DNA
CETN4P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details MBS6401827-01 0.1 mL
Prostein (Solute Carrier Family 45 Member 3, Prostate Cancer-associated Protein 6, SLC45A3, PCANAP6, PRST, IPCA-2, IPCA6, IPCA-6, IPCA-8) (FITC)
Sign In for Pricing
View Details 
MBS6401827-02 5x 0.1 mL
Prostein (Solute Carrier Family 45 Member 3, Prostate Cancer-associated Protein 6, SLC45A3, PCANAP6, PRST, IPCA-2, IPCA6, IPCA-6, IPCA-8) (FITC)
Sign In for Pricing
View Details